Mir-152 inhibits cell proliferation and colony formation of CD133+ liver cancer stem cells by targeting KIT
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mir-152 inhibits cell proliferation and colony formation of CD133+ liver cancer stem cells by targeting KIT
Authors
Keywords
miR-152, KIT, Liver cancer stem cells, Proliferation
Journal
TUMOR BIOLOGY
Volume 36, Issue 2, Pages 921-928
Publisher
Springer Nature
Online
2014-10-14
DOI
10.1007/s13277-014-2719-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness
- (2015) Helge Siemens et al. Oncotarget
- C-Kit and Its Ligand Stem Cell Factor: Potential Contribution to Prostate Cancer Bone Metastasis
- (2015) Christoph Wiesner et al. NEOPLASIA
- Changing Hepatocellular Carcinoma Incidence and Liver Cancer Mortality Rates in the United States
- (2014) Sean F Altekruse et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Attributable Causes of Liver Cancer Mortality and Incidence in China
- (2014) Jin-Hu Fan et al. Asian Pacific Journal of Cancer Prevention
- MicroRNA-181a promotes tumor growth and liver metastasis in colorectal cancer by targeting the tumor suppressor WIF-1
- (2014) Dengbo Ji et al. Molecular Cancer
- MicroRNA-137 down-regulates KIT and inhibits small cell lung cancer cell proliferation
- (2013) Peipei Li et al. BIOMEDICINE & PHARMACOTHERAPY
- MiR-17-92 and miR-221/222 cluster members target KIT and ETV1 in human gastrointestinal stromal tumours
- (2013) C M M Gits et al. BRITISH JOURNAL OF CANCER
- c-Kit Is Suppressed in Human Colon Cancer Tissue and Contributes to L1-Mediated Metastasis
- (2013) N. Gavert et al. CANCER RESEARCH
- MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer
- (2013) Hongping Xia et al. HEPATOLOGY
- MicroRNA-192 suppresses liver metastasis of colon cancer
- (2013) L Geng et al. ONCOGENE
- Metformin, a Diabetes Drug, Eliminates Tumor-Initiating Hepatocellular Carcinoma Cells
- (2013) Tomoko Saito et al. PLoS One
- miR-152 controls migration and invasive potential by targeting TGFα in prostate cancer cell lines
- (2013) Chen Zhu et al. PROSTATE
- MicroRNA-218 inhibits gastrointestinal stromal tumor cell and invasion by targeting KIT
- (2013) Rong Fan et al. TUMOR BIOLOGY
- The biological implication of cancer stem cells in hepatocellular carcinoma: a possible target for future therapy
- (2013) Caecilia H C Sukowati et al. Expert Review of Gastroenterology & Hepatology
- Liver cancer incidence and mortality in China, 2009
- (2013) Wan-Qing Chen et al. Chinese Journal of Cancer
- Liver tumor-initiating cells as a therapeutic target for hepatocellular carcinoma
- (2012) Terence Kin Wah Lee et al. CANCER LETTERS
- MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3
- (2012) Xuguang Zheng et al. CANCER LETTERS
- Trends in Liver Cancer Mortality Rates in Japan, USA, UK, France and Korea Based on the WHO Mortality Database
- (2012) T. Matsuda et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin–ATP-binding cassette G2 signaling
- (2012) W K Chau et al. ONCOGENE
- microRNA-152 Mediates DNMT1-Regulated DNA Methylation in the Estrogen Receptor α Gene
- (2012) Yung-Song Wang et al. PLoS One
- CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma
- (2011) Lian Shu Piao et al. CANCER LETTERS
- miR-152 Is a Tumor Suppressor microRNA That Is Silenced by DNA Hypermethylation in Endometrial Cancer
- (2011) T. Tsuruta et al. CANCER RESEARCH
- MicroRNA-494 Downregulates KIT and Inhibits Gastrointestinal Stromal Tumor Cell Proliferation
- (2011) W. K. Kim et al. CLINICAL CANCER RESEARCH
- MicroRNA-193b regulates c-Kit proto-oncogene and represses cell proliferation in acute myeloid leukemia
- (2011) Xiao-ning Gao et al. LEUKEMIA RESEARCH
- MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia
- (2011) X-N Gao et al. ONCOGENE
- MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo
- (2011) X-X He et al. ONCOGENE
- miR-130b Promotes CD133+ Liver Tumor-Initiating Cell Growth and Self-Renewal via Tumor Protein 53-Induced Nuclear Protein 1
- (2010) Stephanie Ma et al. Cell Stem Cell
- Mortality trends for primary liver cancer in Puglia, Italy
- (2010) Enzo Coviello et al. EUROPEAN JOURNAL OF CANCER PREVENTION
- Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1
- (2010) Jinfeng Huang et al. HEPATOLOGY
- MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2
- (2010) Linhui Liang et al. HEPATOLOGY
- Down-regulation of miR-221 and miR-222 correlates with pronounced Kit expression in gastrointestinal stromal tumors
- (2010) Koelz INTERNATIONAL JOURNAL OF ONCOLOGY
- MicroRNA-148/152 Impair Innate Response and Antigen Presentation of TLR-Triggered Dendritic Cells by Targeting CaMKII
- (2010) X. Liu et al. JOURNAL OF IMMUNOLOGY
- Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells
- (2010) F Yu et al. ONCOGENE
- Cancer stem cells in hepatocellular carcinoma: Recent progress and perspective
- (2009) Tetsuhiro Chiba et al. CANCER LETTERS
- MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells
- (2009) Qing Ji et al. PLoS One
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started